AXIM BIOTECHNOLOGIES, INC.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $134.2K $661.1K $127 $19.1K $23.1K $0
Accounts Receivable
Inventory $200.8K $0
Total Current Assets $1.2M $738.5K $3.1K $39.1K $88.1K
Property, Plant & Equipment $15.7K $0
Goodwill
Intangible Assets (Excl. Goodwill) $53.7K $93.7K $50.0K $0
Total Assets $1.3M $738.5K $56.8K $132.8K $137.3K $0
Liabilities
Accounts Payable $5.5K $0
Total Current Liabilities $2.5M $1.3M $150.7K $137.5K $127.1K $0
Long-Term Debt
Total Liabilities $3.0M $1.3M $150.7K $137.5K $62.1K $0
Stockholders' Equity
Retained Earnings $-10.8M $-692.0K $-19.8K $-4.9K $-2.1K
Total Stockholders' Equity $-1.7M $-580.7K $-93.9K $-4.7K $10.2K $0
← Newer Page 2 of 2 Older →